Three state boards of pharmacy recently issued licensee communications that contained incorrect information about FDA guidance on shortage drug compounding by 503A pharmacies.
We have updated our USP state-by-state implementation tracking spreadsheet, and it’s available online here—but only to APC members. This resource shows the status of implementation of USP 795, 797, and 800 chapters in every state.
In a letter sent this week to NABP, FDA clarified its position on the compounding of semaglutide sodium.
Help us help prescribers understand the importance of preserving compounded hormone therapy.
A recent article revealed that the National Academies of Science, Engineering and Medicine reportedly received funds—to the tune of $19 million—from members of the Sackler family.
The California Board of Pharmacy met yesterday to discuss proposed regulations on non-sterile, sterile, and hazardous compounding.
Looking for a way to enhance your compounding pharmacy or facility's capabilities, keep your team up-to-date on industry developments, and connect with fellow compounding professionals?
APC this week asked FDA’s Center for Veterinary Medicine to provide additional guidance on compliance with its GFI 256 on animal drug compounding.
APC this week wrote to the Tennessee Board of Pharmacy to express concern that the board has not shown evidence that two proposed compounding-related regulations will improve patient safety.
APC this week submitted a comment letter expressing concern over the California Board of Pharmacy's proposed changes to regulations related to sterile compounding.
This week APC sent a comment letter to the Montana Senate Business, Labor, and Economic Affairs Committee considering HB 152, which recently passed the Montana house.
The recent withdrawal of Makena by the FDA has created complications for pharmacy compounders, particularly regarding the use of hydroxyprogesterone.
The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal for conscientious compounding pharmacists.
Small Business Rising is a grassroots organization advocating for policies that support small businesses. Compounding pharmacy owners can join their mailing list to stay informed about relevant legislation and advocacy efforts.
In a letter sent this week to FDA’s Center for Veterinary Medicine, APC corrected misleading input provided to the agency in a February comment letter from the Animal Health Institute and Generic Animal Drug Alliance.
We’re calling for nominations for the 2023 APC Fellows Program. This program recognizes the distinguished contributions made by compounding pharmacist and pharmacy technician members to the profession and their communities.
FDA has added quinacrine hydrochloride to its list of bulk drug substances that can be used in compounding by outsourcing facilities...
Find out what you need to know about GFI 256 by purchasing access to the recent GFI 256 compliance webinar, sponsored by APC and PCCA. It’s now available on-demand until June 15 for $25 (no CE credit).
APC members Stuart Johnson and his wife Brandi, of Aiken, SC, didn’t know their US Senator Tim Scott, but they signed up to meet with his staffer last September during Compounders on Capitol Hill.
Yesterday, the House Energy and Commerce Committee's Health Subcommittee held a hearing on reauthorizing the animal drug user fee...
Earlier this week, APC hosted its third annual Owner Summit in Point Clear, Alabama.
In recent weeks there’s been a persistent rumor that the governing body for horse-racing has banned compounded drugs because they are not FDA approved. But that’s not the case.
Later this spring, we’ll be debuting a new 15-hour certificate program, “The Ethical, Legal, and Regulatory Framework of Pharmacy Compounding.”
The California Board of Pharmacy’s Enforcement and Compounding Committee met yesterday to discuss proposed regulations related to sterile compounding.
Check out the latest public policy update video from APC Director of Public Policy Savannah Cunningham, PharmD.
In advance of the April 1, 2023, enforcement date for the new animal compounding guidance from FDA, APC and PCCA are partnering to offer a CE webinar aimed at helping you bring your animal compounding operations into compliance.
In response to a request from APC and NCPA, FDA’s Center for Veterinary Medicine last week issued a Letter to Industry explaining the phased-in approach to enforcement the agency plans to take on GFI 256.
The Prescriber Briefs developed by APC and the Pharmacy Compounding Foundation are excellent resources for educating prescribers about pharmacy compounding—including laws, guidance, and standards you must adhere to.
Since the program’s inception, 112 pharmacists have been nominated to this elite group. Thirteen new members were inducted during last year's Compounders on Capitol Hill.
In advance of the Apr 1, 2023, enforcement date for the new animal compounding guidance from FDA, APC and PCCA are partnering to offer a CE webinar aimed at helping you bring your animal compounding operations into compliance.
FOLLOW US
